Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for synthesizing pitavastatin calcium intermediate by microchannel reactor

A microchannel reactor, pitavastatin calcium technology, applied in chemical instruments and methods, chemical/physical/physical-chemical reactors, chemical/physical/physical-chemical processes, etc., can solve the problem of large reaction volume, severe heat release, There are many problems such as impurities, so as to achieve the effect of mild reaction conditions, simple post-treatment and strong heat transfer ability.

Pending Publication Date: 2021-07-23
JIANGSU ALPHA PHARM CO LTD
View PDF4 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] In the traditional kettle reaction, the reaction volume is large, and the probability of collision between the catalyst and the alkylbenzene is small, resulting in the need for a strong Lewis acid to catalyze the above reaction. In the Chinese patent CN101948382A, although the organic amine trifluoromethanesulfonate is used in the reaction process Salt as a catalyst, but such catalysts are expensive, and will produce triflate and other fluorine-containing solid wastes, which are difficult to handle in the post-treatment process and cause pollution to the environment; The disadvantages of the reaction, such as severe heat release, more impurities, etc.; at the same time, the raw material phthalic anhydride is excessive during the reaction, which is not easy to remove, the whole reaction time is long, and the yield and purity still need to be improved

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for synthesizing pitavastatin calcium intermediate by microchannel reactor
  • Method for synthesizing pitavastatin calcium intermediate by microchannel reactor
  • Method for synthesizing pitavastatin calcium intermediate by microchannel reactor

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] (1) Hypothylation of fluorobenzene, sodium carbonate and dichloromethane, resulting in a homogeneous a solution, a concentration of fluorobenzene in a homogeneous a solution of 1.0 mol / L, sodium carbonate and fluorobenzene 1.5: 1.

[0036] (2) Mixed phthalic anhydride was mixed with dichloromethane to obtain a homogeneous B solution, and the concentration of phthalic anhydride in a homogeneous B solution was 1.5 mol / L.

[0037] (3) The microreactive mixer M and the reaction module L are placed at a predetermined temperature, and the homozygous A solution obtained in step (1) and the homozygs (2) obtained in the step (2) are respectively The pump P1, the second flow pump P2 is pumped into the microreactive mixer M by a flow rate ratio (2: 1), and the first flat stream pip pumps the homogeneous A solution into the microsparic mixer M, and the flow rate is 0.5mL / MIN, mixed uniformly transferred to the reaction module L (inner diameter: 0.1 mm, length: 15 m) for the Fu-gr...

Embodiment 2

[0040] (1) Benzene, lithium carbonate and dichloroethane are mixed uniform to obtain a homogeneous a solution, and the concentration of fluorobenzene in the homogeneous A solution is 2.0 mol / L, the molar ratio of lithium carbonate and fluorobenzene is 2.0: 1. .

[0041] (2) Mixed phthalic anhydride was mixed with dichloroethane to obtain a homogeneous B solution, and the concentration of phthalic anhydride in a homogeneous B solution was 2.5 mol / L.

[0042] (3) The microreactive mixer M and the reaction module L are placed at a predetermined temperature, and the homozygous A solution obtained in step (1) and the homozygs (2) obtained in the step (2) are respectively The pump P1, the second flow pump P2 is pumped into the microspactic mixer M by a flow rate ratio (4: 1), and the first state flow pump P1 pumps the above-mentioned a solution into the microspactic mixer M, which is 10 ml / min. After mixing is uniform, transferred to the reaction module L (inner diameter: 5 mm, le...

Embodiment 3

[0045] (1) Benzene, potassium carbonate and methyl tert-butyl ether are mixed to obtain a homogeneous a solution, and the concentration of fluorobenzene in the homogeneous A solution is 0.1 mol / L, the molar ratio of potassium carbonate and fluorobenzene is 0.5. :1.

[0046] (2) The phthalic anhydride was mixed with methyl tert-butyl ether to obtain a homogeneous B solution, and the concentration of phthalic anhydride in a homogeneous B solution was 0.1 mol / L.

[0047] (3) The microreactive mixer M and the reaction module L are placed at a predetermined temperature, and the homozygous A solution obtained in step (1) and the homozygs (2) obtained in the step (2) are respectively The pump P1, the second flow pump P2 is pumped into the microspactic mixer M by a flow rate ratio (3: 1), and the first state of which pumps the homogeneous A solution into the microspactic mixer M, which is 15 ml / min. After mixing is uniform, transferred to the reaction module L (inner diameter: 10 mm...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Concentrationaaaaaaaaaa
Concentrationaaaaaaaaaa
Concentrationaaaaaaaaaa
Login to View More

Abstract

The invention relates to a method for synthesizing a pitavastatin calcium intermediate in a microchannel reactor. Fluorobenzene and phthalic anhydride are used as raw materials, a target product 2-(4-fluoro-benzoyl)-benzoic acid is synthesized through the microchannel reactor, and in the reaction process, and a carbonate compound is used for replacing aluminum trichloride in the prior art to serve as a catalyst, so the catalyst treatment before industrial production is avoided, meanwhile, a large amount of aluminum-containing wastewater is not generated in the reaction process, the method is green and environment-friendly, the reaction condition is mild, the reaction time is short, the product yield is high and reaches 92% or above, the purity is high and reaches 99% or above, the product post-treatment is simple, the cost is reduced, and the method is suitable for industrial production.

Description

Technical field [0001] The present invention belongs to the art of the drug synthesis, and more particularly to a method of microchannel reactor synthesizing pattycittrine intermediate 2- (4-fluorine-benzoyl)-benzoic acid. Background technique [0002] Pitavastation, NK-104, the first full-synthetic HMG-COA reductase inhibitor jointly developed by two companies in Nissan Chemistry and Xing and Corporate Co., Ltd., which belongs to statins, mainly through hmgco- The inhibition of the hepatic enzyme of the reductase to reduce the ability of the liver to produce cholesterol, and thus improve the elevated serum cholesterol level, mainly used to treat high cholesterol hypermia and family-sex high cholesterolemia, because of its lipid-lowering effect Ok, it is called "super statins". [0003] Among them, Compound 2- (4-fluorine-benzoyl)-benzoic acid is one of the important intermediates of the preparation of guttytin. At present, in the preparation of the intermediate, fluorobenzene an...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07C51/083C07C65/34B01J19/00
CPCC07C51/083B01J19/0093C07C65/34
Inventor 周乃毅石利平徐春涛何义叶金星李大伟程瑞华庞小召马跃跃陆梦云刘思琪
Owner JIANGSU ALPHA PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products